Pan-tumor genomic biomarkers for PD-1 checkpoint blockade–based immunotherapyRăzvan Cristescu, David R. Kaufman, Xinwei Sher et al.|Science|2018Cited by 2.3k
Biomarkers predictive of response to pembrolizumab in head and neck cancerDavid G. Pfister, Joshua Bauml, Robert I. Haddad et al.|Cancer Medicine|2022Cited by 48
Abstract LB-339: Biomarkers predictive of response to pembrolizumab in head and neck cancer (HNSCC)Tanguy Y. Seiwert, Laura Q.M. Chow, Robert I. Haddad et al.|Cancer Research|2018Cited by 38